Browsing by Author "Tufan, Abdurrahman"
Now showing 1 - 17 of 17
- Results Per Page
- Sort Options
Publication A nationwide experience with the off label use of interleukin 1 targeting treatment in familial mediterranean fever patients(Wiley, 2016-10-01) Akar, Servet; Çetin, Pınar; Kalyoncu, Umut; Karadağ, Ömer; Sarı, İsmail; Çınar, Muhammed; Yılmaz, Sedat; Onat, Ahmet Mesut; Kısacık, Bünyamin; Erden, Abdülsamet; Balkarlı, Ayşe; Küçükşahin, Orhan; Öner, Sibel Yılmaz; Şenel, Soner; Tufan, Abdurrahman; Direskeneli, Haner; Öksüz, Mustafa Ferhat; Pehlivan, Yavuz; Bayndır, Özün; Keser, Gökhan; Aksu, Kenan; Omma, Ahmet; Kaşifoğlu, Timuçin; Ünal, Ali Uğur; Yıldız, Fatih; Balcı, Mehmet Ali; Yavuz, Şule; Erten, Şükran; Özgen, Metin; Sayarıoğlu, Mehmet; Doğru, Atalay; Çetin, Gözde Yıldırım; Alibaz-Öner, Fatma; Tezcan, Mehmet Engin; Pamuk, Ömer Nuri; Önen, Fatos; Öksüz, Mustafa Ferhat; PEHLİVAN, YAVUZ; Uludağ Üniversitesi/Tıp Fakültesi/Romatoloji Anabilim Dalı.; JXF-7598-2024; AAG-8227-2021Item Budd-chiari syndrome in behçet's disease: A retrospective multicenter study(Bmj Publishing Group, 2017-06) Tufan, Abdurrahman; Uludağ Üniversitesi/Tıp Fakültesi/ İç Hastalıkları Anabilim Dalı/Romatoloji Bilim Dalı.; 0000-0001-6244-9362; A-7613-2016Publication Clinical features of takayasu's arteritis from an inception cohort: Early disease is characterized by 'systemic inflammation'(Wiley, 2016-10-01) Alibaz-Öner, Fatma; Ünal, Ali Uğur; Onat, Ahmet Mesut; Kısacık, Bünyamin; Zengin, Orhan; Karadağ, Ömer; Erden, Abdulsamet; Yarkan, Handan; Akar, Servet; Yıldız, Fatih; Erken, Eren; Özer, Hüseyin; Omma, Ahmet; Özbalkan, Zeynep; Karaaslan, Yaşar; Bes, Cemal; Öner, Sibel Yılmaz; Kanıtez, Nilüfer Alpay; Bayndır, Özün; Yavuz, Şule; Düzgün, Nursen; Tufan, Ayşe Nur; Dalkılıç, Ediz; Yoshifuji, Hajime; Tufan, Abdurrahman; Akyol, Lütfi; Öztürk, Mehmet Akif; Sayarlıoğlu, Mehmet; Aksu, Kenan; Keser, Gökhan; Kiraz, Sedat; Pamuk, Ömer Nuri; Önen, Fatoş; Direskeneli, Haner; Tufan, Ayse Nur; DALKILIÇ, HÜSEYİN EDİZ; Uludağ Üniversitesi/Tıp Fakültesi/Romatoloji Anabilim Dalı.; GHE-4236-2022; CMF-4757-2022Publication Disease activity indices and body mass index: Cross-sectional analysis of a large psoriatic arthritis cohort(Wiley, 2015-10-01) Kalyoncu, Umut; Bayndar, Ozun; Yilmazer, Barış; Dalkılıç, Hüseyin Ediz; Aksu, Kenan; Öksüz, Mustafa Ferhat; Tarhan, E. Figen; Can, Meryem; Küçükşahin, Orhan; Kimyon, Gezmiş; Akyol, Lütfi; Onat, Ahmet Mesut; Kısacık, Bünyamin; Erden, Abdülsamet; Omma, Ahmet; Bakırlı, Duygu Ersözlü; Özişler, Cem; Gönüllü, Emel; Pehlevan, Seval; Solmaz, Dilek; Çınar, Muhammet; Çetin, Gözde; Tufan, Abdurrahman; Tufan, Müge Aydın; Kılıç, Levent; Erten, Şükran; Kaşifoğlu, Timuçin; Kobak, Şenol; Şenel, Soner; Akar, Servet; Özgen, Metin; Kasapoğlu-Günal, Esen; Yazısız, Veli; Yılmaz, Sedat; Dönmez, Salim; Doğan, İsmail; Köseoğlu, Hamide Kart; Erbasan, Funda; Yıldız, Fatih; Beş, Cemal; Balkarlı, Ayşe; Şahin, Ali; Mercan, Rıdvan; Arslan, Fatoş; Doğru, Atalay; Pay, Salih; Yavuz, Şule; Çakır, Necati; Kabasakal, Yasemin; Aydın, Sibel Z.; DALKILIÇ, HÜSEYİN EDİZ; CMF-4757-2022Item The effect of smoking on response to tumor necrosis factor-alpha inhibitor treatment in ankylosing spondylitis patients: results from the Turkbio registry(BMJ Publishing Group, 2018-06) Tuğsal, Handan Yarkan; Can, Gerçek; Çapar, Sedat; Zengin, Berrin; Kenar, Gökçe; Akar, Servet; Şenel, Soner; Koca, Süleyman Serdar; Tufan, Abdurrahman; Yazıcı, Ayten; İnanç, Nevsun; Ellidokuz, Hülya; Akkoç, Nurullah; Önen, Fatoş; Dalkılıç, Ediz; Uludağ Üniversitesi/Tıp Fakültesi/Romatoloji Bilim Dalı.Item The effect of smoking on response to tumor necrosis factor-alpha inhibitor treatment in ankylosing spondylitis patients: results from the turkbio registry(BMJ Publishing Group, 2018-06) Tuğsal, H. Yarkan; Can, Gerçek; Çapar, Sedat; Zengin, Berrin; Kenar, Gökçe; Akar, Servet; Şenel, Soner; Koca, Süleyman Serdar; Tufan, Abdurrahman; Yazıcı, Ayten; İnanç, Nevsun; Ellidokuz, Hülya; Akkoç, Nurullah; Önen, Fatoş; Dalkılıç, Ediz; Uludağ Üniversitesi/Tıp Fakültesi/Romatoloji Bilim Dalı.Item The effect of smoking on response to tumour necrosis factor-alpha inhibitor treatment in psoriatic arthritis patients: Results from the TURKBIO registry(Wiley, 2018-09) Yarkan, Handan; Kenar, Gökçe; Capar, Sedat; Can, Gerçek; Zengin, Berrin; Akar, Servet; Şenel, Soner; Koca, Süleyman Serdar; Tufan, Abdurrahman; Yüziçi, Ayten; İnanç, Nevsun; Ellidokuz, Hülya; Akkoç, Nurullah; Önen, Fatoş; Dalkılıç, Ediz; Uludağ Üniversitesi/Tıp Fakültesi/Romatoloji Bilim Dalı.Publication Impact of obesity on drug survival of tofacitinib in patients with rheumatoid arthritis: Analysis from the Turkbio registry(Wiley, 2018-09-01) Babaoğlu, Hakan; Göker, Borna; İnanç, Nevsun; Birlik, Merih; Koca, Süleyman Serdar; Cefle, Ayşe; Dalkılıç, Ediz; Tufan, Abdurrahman; Yılmaz, Sema; Şenel, Soner; Akar, Servet; Akkoç, Nurullah; Önen, Fatoş; Gazel, Ummugülsüm; DALKILIÇ, HÜSEYİN EDİZ; Bursa Uludağ Üniversitesi/Tıp Fakültesi; CMF-4757-2022Publication Interim analysis of baseline characteristics and preferences of administration route of rheumatoid arthritis patients who are bio-naive or switched between advanced ra treatments; a multicenter, prospective, observational study(Wiley, 2018-09-01) Direskeneli, Haner; Karadağ, Ömer; Ateş, Aşkın; Tufan, Abdurrahman; İnanç, Nevsun; Koca, Süleyman Serdar; Çetin, Gözde Yıldırım; Akar, Servet; Çınar, Muhammet; Yılmaz, Sedat; Yılmaz, Neslihan; Dalkılıç, Ediz; Beş, Cemal; Özbalkan, Zeynep; Yılmazer, Bariş; Şahin, Ali; Ersözlü, Emine Duygu; Tezcan, Mehmet Engin; Şen, Nesrin; Keser, Gökhan; Tansoker, İlkan; Hacıbedel, Fatma Başak; Helvacıoğlu, Kerem; Günay, Levent Mert; DALKILIÇ, HÜSEYİN EDİZ; Bursa Uludağ Üniversitesi/Tıp Fakültesi; CMF-4757-2022Item Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?(BMJ Publishing Group, 2018-06) İnanç, Nevsun; Özen, Gülşen; Yalçınkaya, Yasemin; Koca, Süleyman Serdar; Can, Gerçek; Karataş, Ahmet; Yazıcı, Ayten; Cefle, Ayşe; Tufan, Abdurrahman; Akar, Servet; Şenel, Soner; Öz, Burak; Akkoç, Nurullah; Önen, Fatoş; Dalkılıç, Ediz; Pehlivan, Yavuz; Uludağ Üniversitesi/Tıp Fakültesi/Romatoloji Bilim Dalı.; CMF-4757-2022; FQP-0451-2022Item Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?(Wiley, 2017-10) İnanç, Nevsun; Özen, Gülşen; Yalçınkaya, Yasemin; Koca, Süleyman Serdar; Can, Gerçek; Karataş, Ahmet; Yazıcı, Ayten; Cefle, Ayşe; Tufan, Abdurrahman; Akar, Servet; Şenel, Soner; Öz, Burak; Akkoç, Nurullah; Önen, Fatoş; Dalkılıç, Ediz; Pehlivan, Yavuz; Uludağ Üniversitesi/Tıp Fakültesi/Romatoloji Anabilim Dalı.; CMF-4757-2022; AAG-8227-2021Item Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients with as(BMJ Publishing Group, 2014-06) Pehlivan, Yavuz; Coşkun, Belkıs N.; Öksüz, Mustafa Ferhat; Dalkılıç, Ediz; Tufan, Abdurrahman; Uludağ Üniversitesi/Tıp Fakültesi/Romatoloji Anabilim Dalı.; 0000-0001-6244-9362; 0000-0003-0298-4157; A-7613-2016; AAG-8227-2021; AAG-7155-2021Item Similar efficacy of tofacitinib on disease activity in rheumatoid arthritis patients with and without previous biologicals; results from the turkbio registry(BMJ Publishing Group, 2018-06) Zengin, Berrin; İnanç, Nevsun; Akar, Servet; Can, Gerçek; Tufan, Abdurrahman; Şenel, S.; Koca, Süleyman Serdar; Çapar, Sedat; Tuğsal, Handan yarkan; Birlik, Merih; Akkoç, Nurullah; Önen, Fatoş; Dalkılıç, Ediz; Uludağ Üniversitesi/Tıp Fakültesi/Romatolojii Anabilim Dalı.Publication The effect of smoking on response to tumor necrosis factor-alpha inhibitor treatment in ankylosing spondylitis patients: Results from the Turkbio registry(Wiley, 2018-09-01) Yarkan, Handan; Can, Gerçek; Çapar, Sedat; Zengin, Berrin; Kenar, Gökce; Akar, Servet; Dalkılıç, Ediz; Şenel, Soner; Koca, Süleyman Serdar; Tufan, Abdurrahman; Yazıcı, Ayten; İnanç, Nevsun; Ellidokuz, Hülya; Akkoç, Nurullah; Önen, Fatoş; DALKILIÇ, HÜSEYİN EDİZ; Bursa Uludağ Üniversitesi/Tıp Fakültesi/ Dahiliye Bölümü; CMF-4757-2022Publication The efficacy and safety of anti-TNFα treatment in ankylosing spondylitis patients with late onset compared to those with adult onset; the data from TURKBIO registry(Wiley, 2019-10-01) Uslu, Sadettin; Can, Gerçek; Cefle, Ayşe; Yılmaz, Sema; Kocaer, Sinem Burcu; İnel, Tuba Yüce; Gülle, Semih; Koca, Süleyman Serdar; Yolbaş, Şervet; Öztürk, Mehmet Akif; Şenel, Soner; İnanc, Nevsun; Dalkılıç, Ediz; Gündüz, Özgül; Tufan, Abdurrahman; Akar, Servet; Birlik, Merih; Sarı, İsmail; Akkoç, Nurullah; Önen, Fatoş; DALKILIÇ, HÜSEYİN EDİZ; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Romatoloji Anabilim Dalı.; JHC-5173-2023Item Use of biological dmards in patients with primary vasculitis; results from turkbio registry(Bmj Publishing Group, 2018) Yazıcı, Ayten; Cefle, Ayşe; Can, Gerçek; Göker, Berna; Tufan, Abdurrahman; Şenel, Soner; Koca, Suleyman Serdar; Akar, Servet; Akkoç, Nurullah; Önen, Fatoş; Dalkılıç, Ediz; Pehlivan, Yavuz; Uludağ Üniversitesi/Tıp Fakültesi/Romatoloji Anabilim Dalı.; CMF-4757-2022; AAG-8227-2021Item What are the main barriers to achieve minimal disease activity in psoriatic arthritis in real life?(Clinical & Exper Rheumatology, 2019-09) Bakırcı, Sibel; Solmaz, Dilek; Al Osaimi, Noura; Can, Meryem; Erden, Abdulsamed; Özişler, C.; Çınar, Muhammet; Kılıç, Levent; Küçük, A.; Omma, Ahmet; Yıldız, Fatih; Doğru, Atalay; Esmen, Serpil Ergülü; Akar, Servet; Kalyoncu, Umut; Aydın, Sibel Zehra; Tufan, Abdurrahman; Dalkılıç, Ediz; Bursa Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Romatoloji Bilim Dalı.; CMF-4757-2022; 6506739457Objective: Minimal disease activity (MDA) is an important target in patients with psoriatic arthritis (PsA), however it is also criticised for having a low threshold for patient reported outcomes (PRO). The aim of the study was to assess the prevalence of MDA and its components in patients with PsA and to evaluate disease characteristics and patterns in patients with or without MDA (MDA(+) or MDA(-)).MethodsPsArt-ID (Psoriatic Arthritis-International Database) is a prospective, multicentre web-based registry. PsA patients who had at least 1 year of disease duration and had full data for MDA were included for this analysis (n=317). Patients were considered in MDA+ when they met at least 5/7 of the MDA criteria.ResultsMDA was achieved in 46% patients. Within MDA- patients, body surface area (51.2%) and swollen joint count (53.5%) domains could still be achieved in the majority and 93.5% of them had no enthesitis using the Leeds enthesitis index. Of 170 patients with MDA-, 90 patients did not fulfill all 3 PROs of MDA. Mono-arthritis subtype (RR: 2.01), absence of enthesitis (RR: 1.570) and absence of distal interphalangeal (DIP) joint disease (RR: 1.1) were associated with higher probability of achieving MDA.ConclusionThe MDA criteria provide an objective target for treatment in trials and clinical practice; however, in real life PROs are the most significant barriers to achieve MDA. The presence of DIP joints disease makes it difficult to reach MDA due to active PROs.